These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 22067974)

  • 1. Study on formulation variables of methotrexate loaded mesoporous MCM-41 nanoparticles for dissolution enhancement.
    Vadia N; Rajput S
    Eur J Pharm Sci; 2012 Jan; 45(1-2):8-18. PubMed ID: 22067974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate.
    Ambrogi V; Perioli L; Marmottini F; Giovagnoli S; Esposito M; Rossi C
    Eur J Pharm Sci; 2007 Nov; 32(3):216-22. PubMed ID: 17826966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Econazole nitrate-loaded MCM-41 for an antifungal topical powder formulation.
    Ambrogi V; Perioli L; Pagano C; Marmottini F; Moretti M; Mizzi F; Rossi C
    J Pharm Sci; 2010 Nov; 99(11):4738-45. PubMed ID: 20845470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
    Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol.
    Wang Y; Sun L; Jiang T; Zhang J; Zhang C; Sun C; Deng Y; Sun J; Wang S
    Drug Dev Ind Pharm; 2014 Jun; 40(6):819-28. PubMed ID: 23594300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization and pH-controllable methotrexate release from biocompatible polymer/silica nanocomposite for anticancer drug delivery.
    Rasouli S; Davaran S; Rasouli F; Mahkam M; Salehi R
    Drug Deliv; 2014 May; 21(3):155-63. PubMed ID: 24107075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective controlled release of captopril by silylation of mesoporous MCM-41.
    Qu F; Zhu G; Huang S; Li S; Qiu S
    Chemphyschem; 2006 Feb; 7(2):400-6. PubMed ID: 16411260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.
    Kim MS; Jin SJ; Kim JS; Park HJ; Song HS; Neubert RH; Hwang SJ
    Eur J Pharm Biopharm; 2008 Jun; 69(2):454-65. PubMed ID: 18359211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
    Ibrahim AH; Smått JH; Govardhanam NP; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM
    Eur J Pharm Sci; 2020 Jan; 142():105103. PubMed ID: 31648050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of indomethacin nanoparticles into 3-D ordered macroporous silica for enhanced dissolution and reduced gastric irritancy.
    Hu Y; Zhi Z; Wang T; Jiang T; Wang S
    Eur J Pharm Biopharm; 2011 Nov; 79(3):544-51. PubMed ID: 21767643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan.
    Zhang Y; Zhi Z; Jiang T; Zhang J; Wang Z; Wang S
    J Control Release; 2010 Aug; 145(3):257-63. PubMed ID: 20450945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrospray fabrication of doxorubicin-chitosan-tripolyphosphate nanoparticles for delivery of doxorubicin.
    Songsurang K; Praphairaksit N; Siraleartmukul K; Muangsin N
    Arch Pharm Res; 2011 Apr; 34(4):583-92. PubMed ID: 21544723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissolution rate enhancement of the poorly water-soluble drug Tibolone using PVP, SiO2, and their nanocomposites as appropriate drug carriers.
    Papadimitriou S; Bikiaris D
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1128-38. PubMed ID: 19555245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanogated vessel based on polypseudorotaxane-capped mesoporous silica via a highly acid-labile benzoic-imine linker.
    Gao Y; Ma R; An Y; Shi L
    J Control Release; 2011 Nov; 152 Suppl 1():e81-2. PubMed ID: 22195943
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular interactions, internal structure and drug release kinetics of rationally developed polymer-lipid hybrid nanoparticles.
    Li Y; Wong HL; Shuhendler AJ; Rauth AM; Wu XY
    J Control Release; 2008 May; 128(1):60-70. PubMed ID: 18406489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of SBA-15 for furosemide oral delivery enhancement.
    Ambrogi V; Perioli L; Pagano C; Marmottini F; Ricci M; Sagnella A; Rossi C
    Eur J Pharm Sci; 2012 May; 46(1-2):43-8. PubMed ID: 22365882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of particle morphology, pore size and surface coating of mesoporous silica on Naproxen dissolution rate enhancement.
    Guo Z; Liu XM; Ma L; Li J; Zhang H; Gao YP; Yuan Y
    Colloids Surf B Biointerfaces; 2013 Jan; 101():228-35. PubMed ID: 23010024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.
    Zhang Y; Wang J; Bai X; Jiang T; Zhang Q; Wang S
    Mol Pharm; 2012 Mar; 9(3):505-13. PubMed ID: 22217205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole.
    Kinnari P; Mäkilä E; Heikkilä T; Salonen J; Hirvonen J; Santos HA
    Int J Pharm; 2011 Jul; 414(1-2):148-56. PubMed ID: 21601623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery.
    Tang H; Guo J; Sun Y; Chang B; Ren Q; Yang W
    Int J Pharm; 2011 Dec; 421(2):388-96. PubMed ID: 22001840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.